KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Shares Issued (2016 - 2025)

Historic Shares Issued for Arbutus Biopharma (ABUS) over the last 16 years, with Q3 2025 value amounting to $794000.0.

  • Arbutus Biopharma's Shares Issued fell 5006.29% to $794000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year decrease of 1143.29%. This contributed to the annual value of $7.5 million for FY2024, which is 129757.01% up from last year.
  • As of Q3 2025, Arbutus Biopharma's Shares Issued stood at $794000.0, which was down 5006.29% from $453000.0 recorded in Q2 2025.
  • Over the past 5 years, Arbutus Biopharma's Shares Issued peaked at $2.7 million during Q1 2025, and registered a low of -$115000.0 during Q4 2021.
  • Its 5-year average for Shares Issued is $961133.3, with a median of $453000.0 in 2025.
  • In the last 5 years, Arbutus Biopharma's Shares Issued plummeted by 10057.0% in 2021 and then skyrocketed by 319130.43% in 2024.
  • Quarter analysis of 5 years shows Arbutus Biopharma's Shares Issued stood at -$115000.0 in 2021, then surged by 238.26% to $159000.0 in 2022, then plummeted by 128.93% to -$46000.0 in 2023, then soared by 3191.3% to $1.4 million in 2024, then crashed by 44.16% to $794000.0 in 2025.
  • Its Shares Issued was $794000.0 in Q3 2025, compared to $453000.0 in Q2 2025 and $2.7 million in Q1 2025.